DWM
TEVA icon

Diversify Wealth Management’s Teva Pharmaceuticals TEVA Stock Holding History

Diversify Wealth Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.2M Buy
70,713
+8,805
+14% +$293K 0.04% 378
2026
Q1 		$2.19M Buy
61,908
+54,488
+734% +$1.75M 0.04% 354
2025
Q4 		$241K Buy
+7,420
New +$183K 0.01% 563
2025
Q1 		– Sell
-42,759
Closed -$895K – 550
2024
Q4 		$895K Buy
42,759
+7,969
+23% +$145K 0.07% 233
2024
Q3 		$640K Buy
+34,790
New +$609K 0.06% 262

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Diversify Wealth Management's TEVA Position: Q2 2026 in Review

Diversify Wealth Management increased its Teva Pharmaceuticals (TEVA) stake by 14% in Q2 2026, buying an estimated $293K and bringing the position to 70,713 shares worth $2.2M. The position accounts for 0.04% of the portfolio, ranked #378.

Diversify Wealth Management first reported a position in TEVA in Q3 2024 and has held it in 5 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Diversify Wealth Management held 70,713 shares of Teva Pharmaceuticals worth $2.2M as of Q2 2026.
  • Diversify Wealth Management bought 8,805 Teva Pharmaceuticals shares in Q2 2026, an estimated $293K.
  • Teva Pharmaceuticals made up 0.04% of Diversify Wealth Management's portfolio in Q2 2026, its #378 holding.
  • Diversify Wealth Management first reported a position in Teva Pharmaceuticals in Q3 2024 and has held it in 5 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Diversify Wealth Management's 13F filing for Q2 2026, filed 30 Jul 2026.